Variables | Total | P-value | NIPPV prior to IMV | Only IMV | p-value |
---|---|---|---|---|---|
All Patients | N=54 Deaths 34 [63.0%] |
N=27 Deaths 17 [63.0%] |
N=27 Deaths 17 [63.0%] |
1.00 | |
Deaths/n | Deaths/n | Deaths/n | |||
BMI <26.9 26.9+ |
13/27 [48.1%] 21/27 [77.8%] |
0.047 |
5/12 [41.7%] 12/15 [80.0%] |
8/15 [53.3%] 9/12 [75.0%] |
0.70 1.00 |
Age <65 65+ |
11/22 [50.0%] 23/32 [71.9%] |
0.15 |
3/9 [33.3%] 14/18 [77.8%] |
8/13 [61.5%] 9/14 [64.3%] |
0.39 0.45 |
Gender Female Male |
15/24 [62.5%] 19/30 [63.3%] |
1.00 |
9/13 [69.2%] 8/14 [57.1%] |
6/11 [54.5%] 11/16 [68.8%] |
0.68 0.71 |
ILD Subtype IPF CTDs Sarcoidosis Other |
7/8 [87.5%] 12/17 [70.6%] 1/7 [14.3%] 14/22 [63.6%] |
0.027 |
1/2 [50.0%] 5/8 [62.5%] 1/4 [25.0%] 10/13 [76.9%] |
6/6 [100.0%] 7/9 [77.8%] 0/3 [0.0%] 4/9 [44.4%] |
0.25 0.62 1.00 0.19 |
ILD Duration ILD <1 year ILD ≥1 year |
19/24 [79.2%] 15/30 [50.0%] |
0.046 |
10/11 [90.9%] 7/16 [43.8%] |
9/13 [69.2%] 8/14 [57.1%] |
0.33 0.72 |
Supplemental O2 Prescribed Not prescribed |
12/25 [48.0%] 22/29 [75.9%] |
0.049 |
8/15 [53.3%] 9/12 [75.0%] |
4/10 [40.0%] 13/17[76.5%] |
0.69 1.00 |
Pulmonary Hypertension Present Not Present |
18/28 [64.3%] 16/26 [61.5%] |
1.00 |
7/14 [50.0%] 10/13 [76.9%] |
11/14 [78.6%] 6/13 [46.2%] |
0.24 0.23 |
History of CTD Present Not Present |
16/27 [59.3%] 18/27 [66.7%] |
0.78 |
8/14 [57.1%] 9/13 [69.2%] |
8/13 [61.5%] 9/14 [64.3%] |
1.00 1.00 |
Cause of ARF Pneumonia/Sepsis ILD Exacerbation All others |
21/33 [63.6%] 7/9 [77.8%] 6/12 [50.0%] |
0.45 |
9/17 [52.9%] 5/6 [83.3%] 3/4 [75.0%] |
12/16 [75.0%] 2/3 [66.7%] 3/8 [37.5%] |
0.28 1.00 0.55 |
SVTs Sinus Tachycardia All Other SVTs |
11/21 [52.4%] 20/25 [80.0%] |
0.06 |
4/7 [57.1%] 12/15 [80.0%] |
7/14 [50.0%] 8/10 [80.0%] |
1.00 1.00 |
Vasopressor Used Not used |
30/44 [68.2%] 2/8 [25.0%] |
0.043 |
15/22 [68.2%] 0/3 [0.0%] |
15/22 [68.2%] 2/5 [40.0%] |
1.00 0.46 |
Pulmonary Vasodilator Used Not Used |
15/22 [68.2%] 13/26 [50.0%] |
0.25 |
5/8 [62.5%] 8/15 [53.3%] |
10/14 [71.4%] 5/11 [45.5%] |
1.00 1.00 |
Steroid Use Pulse/Stress Dose Other Dose |
19/22 [86.4%] 10/26 [38.5%] |
0.001 |
11/13 [84.6%] 6/14 [42.9%] |
8/9 [88.9%] 4/12 [33.3%] |
1.00 0.70 |